Revelation Pharma Completes Fifteenth Acquisition – Stanley Specialty Pharmacy

Revelation Pharma Completes Fifteenth Acquisition – Purchases Stanley Specialty Pharmacy

TAMPA, Fla., – Osceola Capital (“Osceola”), a lower middle-market private equity firm, announced today the fifteenth addition to the Revelation Pharma Corporation (“Revelation”) platform. Revelation purchased Stanley Specialty Pharmacy located in Charlotte, North Carolina. Stanley Specialty Pharmacy is a PCAB accredited, 503A compounding pharmacy that is dedicated to enhancing the quality of patients’ lives through creative, individualized pharmaceutical treatments and incomparable customer care.

The purchase of Stanley Specialty Pharmacy signifies Revelation’s continuous objective to create a network of 503A and 503B compounding pharmacies across the country. Compounding pharmacies prepare high-quality, tailored prescriptions to meet a specific therapeutic need, often enhancing patients’ quality of life. 

“As a compounding industry veteran, I have witnessed the numerous changes and difficulties that our industry has undergone. Operational complexity brought on by ever-increasing regulatory requirements makes it challenging for a stand-alone business to function, expand, and develop effectively and economically. The individuals in our field that I consider to be the best of the best have been gathered by Revelation Pharma. This group’s combined brain trust will have unparalleled synergy. I’m thrilled to be a member of this group and help it succeed in the future. The excitement of being a part of something greater is shared by my staff. The Stanley staff  will have the skills and resources to further their own careers thanks to RPC’s resources and scale. ”, said Doug Yoch, PharmD, owner of Stanley Specialty Pharmacy. Doug Yoch, PharmD will continue to work as a Clinical Liaison for the Men’s Health Line as a member of the Revelation Clinical Team.

The corporate team for Revelation is led by Pharmacist Shawn Hodges, the former CEO and President of Innovation Compounding, now current CEO of Revelation. Serving as Chairman of the Board, Pharmacist Jake Beckel, has deep experience in the compounding space. He most recently served as founder and CEO of AnazaoHealth Corporation, a leading compounding pharmacy that successfully completed 13 acquisitions and ultimately was acquired by Fagron, the world’s largest publicly traded compounding company. Richard Case serves as President M&A; he is a healthcare M&A industry veteran and has significant experience in the acquisitions of healthcare businesses that operate in highly regulated industries. Jake Beckel and Richard Case, the founders of Revelation, who sit on the board of directors, will solely focus on helping new companies that wish to join Revelation. Mitchell Bell PharmD., is the Senior Vice President of 503A Pharmacies and was previously the Vice President of Operations at Innovation Compounding. Will Skinner is the Chief Financial Officer who has specialized in start-ups, alternative investment companies, and healthcare organizations. Jon Pritchett PharmD., former Pharmacy Program Director at Accreditation Commission for Health Care (ACHC), now serves as the Vice President of Quality Assurance and Regulatory Affairs. 

The number of pharmaceutical collaborations in the works is gradually increasing. Even while pharmacy owners acknowledge the need for support in reacting to regulatory changes, they still wish to undertake pharmacy compounding and serve their patients’ particular healthcare requirements. Revelation’s long-term goal is to become the market leader in compounding by supporting and acquiring pharmacies while building a complete quality assurance system throughout the whole network. 

About Osceola Capital Management 

Osceola Capital is a Tampa-based private equity firm that invests in lower middle-market services companies, typically with EBITDA of $2 million to $10 million. Osceola has extensive experience partnering with management teams to execute buy-and-build strategies and drive long-term value creation. The Revelation Strategy Team includes Ben Moe, and Patrick Watkins. To learn more, visit

About Revelation Pharma Corporation 

Revelation Pharma is a national network of 503A and 503B compounding pharmacies providing innovative and quality pharmaceutical products and services through “industry best” patient care and solutions for customers. Compounding pharmacy will drastically change in the next five years. Revelation believes that compounding pharmacies will need help and support to adjust to these changes in order to continue to serve the needs of the patient and their healthcare provider. 

About Stanley Specialty Pharmacy 

Stanley Specialty Pharmacy has a committed team of experts, including Compounding Pharmacists, Veterinary Pharmacists, Men’s Health Specialists, Hormone Specialists, and more, who are dedicated to serving patients in the Greater Charlotte area, North Carolina, South Carolina, and Texas.



Olivia Scott 

Director of Marketing Communications

Proud Pharmacy Member - Alliance for Pharmacy Compounding

Change the future of compounding pharmacy with us

If you have any specific questions about what an exit/partnership opportunity looks like with Revelation, please contact